Pharmafile Logo
Pharmafocus logo
Advanced Search

sleep apnoea

Showing 3 posts of 3 posts found.

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024
Research and Development Ear Nose & throat, Eli Lilly, clinical trial, sleep apnoea, tirzepatide

Eli Lilly has announced positive topline results from its SURMOUNT-OSA phase 3 trials which demonstrated that tizepatide injection (10mg or …

News

ZOLL remedē System receives FDA approval for sleep apnoea treatment

May 25, 2023
Medical Communications Ear Nose & throat, FDA, ZOLL, sleep apnoea

ZOLL Medical Corporation has announced that it has received approval from the US Food and Drug Administration (FDA) for its …

News
jazz_pharma

FDA authorises Jazz Pharma’s sleep disorder therapy Sunosi

March 22, 2019
Medical Communications, Sales and Marketing FDA, jazz pharmaceuticals, pharma, sleep apnoea

Jazz Pharmaceuticals has announced that its dopamine and norepinephrine reuptake inhibitor (DNRI) Sunosi (solriamfetol) has been approved by the FDA …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026